Alota, Jhaydeil A.

HRN: 23-12-81  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
CEFUROXIME 750MG (VIAL)
06/02/2023
06/08/2023
IV
750mg
Q8hr
Urinary Tract Infection
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes